DE1213851B - Process for the preparation of new pharmaceutically valuable thiophene compounds - Google Patents

Process for the preparation of new pharmaceutically valuable thiophene compounds

Info

Publication number
DE1213851B
DE1213851B DED40465A DED0040465A DE1213851B DE 1213851 B DE1213851 B DE 1213851B DE D40465 A DED40465 A DE D40465A DE D0040465 A DED0040465 A DE D0040465A DE 1213851 B DE1213851 B DE 1213851B
Authority
DE
Germany
Prior art keywords
preparation
mol
general formula
phenyl
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DED40465A
Other languages
German (de)
Inventor
Dr Kurt Thiele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DED37431A priority Critical patent/DE1194424B/en
Priority to CH1147162A priority patent/CH429760A/en
Priority to FI621835A priority patent/FI42572C/en
Priority to BR143797/62A priority patent/BR6243797D0/en
Priority to GB39127/62A priority patent/GB970445A/en
Priority to SE11930/62A priority patent/SE311168B/xx
Priority to DK246264AA priority patent/DK105595C/en
Priority to DK483762AA priority patent/DK105813C/en
Priority claimed from DED40401A external-priority patent/DE1199783B/en
Application filed by Degussa GmbH filed Critical Degussa GmbH
Priority to DED40465A priority patent/DE1213851B/en
Priority claimed from DED40471A external-priority patent/DE1219038B/en
Priority to BE628104A priority patent/BE628104A/en
Priority to SE13233/63A priority patent/SE309601B/xx
Publication of DE1213851B publication Critical patent/DE1213851B/en
Priority to FI691216A priority patent/FI42577C/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Description

Verfahren zur Herstellung neuer pharmazeutisch wertvoller Thiophenverbindungen Zusatz zum Patent: 1 194424 Das Hauptpatent 1194 424 betrifft ein Verfahren zur Herstellung von Verbindungen der allgemeinen Formel und deren Salzen, wobei in der angegebenen Formel R1 ein Wasserstoffatom oder eine niedrigmolekulare Alkylgruppe und R2 ein Wasserstoff- oder Halogen atom oder eine Hydroxyl- oder eine Alkoxygruppe bedeutet.Process for the production of new pharmaceutically valuable thiophene compounds Addition to patent: 1 194424 The main patent 1194 424 relates to a process for the production of compounds of the general formula and their salts, where in the given formula R1 is a hydrogen atom or a low molecular weight alkyl group and R2 is a hydrogen or halogen atom or a hydroxyl or an alkoxy group.

Diese Verbindungen besitzen eine zentralstimulierende und coronargefäßerweiternde Wirkung. These compounds have a central stimulating and coronary vasodilator function Effect.

Bei der weiteren Ausbildung dieses Verfahrens wurde gefunden, daß man Verbindungen der angegebenen Formel auch dadurch herstellen kann, daß man in an sich bekannter Weise a) eine Verbindung der allgemeinen Formel an Stelle von 2-Thienyllithium mit 2-Thienylmagnesiumbromid umsetzt oder b) eine Verbindung der allgemeinen Formel an Stelle von Phenylmagnesiumbromid mit Phenyllithium umsetzt und gegebenenfalls die erhaltenen Basen in an sich bekannter Weise in ihre Salze überführt.In the further development of this process, it was found that compounds of the formula given can also be prepared by a) a compound of the general formula in a manner known per se in place of 2-thienyllithium with 2-thienylmagnesium bromide or b) a compound of the general formula instead of phenylmagnesium bromide is reacted with phenyllithium and, if appropriate, the bases obtained are converted into their salts in a manner known per se.

Beispiel 1 2-'N-[3-Phenyl-3-thienyl-(2)-3-hydroxy-propyl-(1)]-amino:-3-phenyl-propan Aus 4,8 g (0,2 Mol) Mg-Spänen und 32,6 g (0,2 Mol? 2-Bromthiophen wird in 100 ml absolutem Athe in üblicher Weise die Grignardlösung bereitet. Zu dieser Lösung läßt man 60,6 g (0,2 Mol) 2-IN-[3-Phenyl-3 -oxo-propyl-(l)l-amino)-3 -phenyl-propan-HC1, in 500 ml Ather suspendiert, eintropfen. Die Reaktion ist danach sofort beendet. Es wird mit 50 g Ammoniumchlorid in 150 ml Wasser zersetzt. Die Base wird in ätherischer Lösung mit isopropanolischer HCI neutralisiert. Man erhält 47 g HCI-Salz, das aus Isopropanol umkristallisiert wird. F. 1900C.Example 1 2-'N- [3-Phenyl-3-thienyl- (2) -3-hydroxypropyl- (1)] -amino: -3-phenyl-propane The Grignard solution is prepared in the usual way from 4.8 g (0.2 mol) of Mg turnings and 32.6 g (0.2 mol of 2-bromothiophene in 100 ml of absolute athe. 60.6 g of this solution are added (0.2 mol) 2-IN- [3-phenyl-3-oxo-propyl- (l) l-amino) -3-phenyl-propane-HCl, suspended in 500 ml of ether, drop in. The reaction is then ended immediately. It is decomposed with 50 g of ammonium chloride in 150 ml of water. The base is neutralized in an ethereal solution with isopropanolic HCI. 47 g of HCl salt are obtained, which is recrystallized from isopropanol. F. 1900C.

Beispiel 2 2-{N- [3-Phenyl-3-thienyl-(2)-3-hydroxy-propyl-(1)]-amino)3 -(p-chlprphenyl)-propan Aus 3,5 g (0,145 Mol) Mg-Spänen und 23,6 g (0,145 Mol) 2-Bromthiophen wird in 50 ml absolutem Äther in üblicher Weise die Grignardverbindung bereitet. Diese Lösung wird mit einer Suspension von 23 g (0,068 Mol) (N-[3-p-Chlorphenyl -propyl - (2) - aminoj - äthyl}-phenyl - keton -HCl in 250 ml absolutem Äther versetzt und 4 Stunden gekocht. Anschließend wird mit 20 g Ammoniumchlorid in 100 ml Wasser zersetzt, die Ätherlösung mit Pottasche getrocknet und destilliert. Man erhält 12,8 g Base vom Kp.oa = 250 bis 252"C. In isopropanolischer Lösung wird mit isopropanolischer Maleinsäurelösung ein Maleinat erhalten, das, aus Isopropanol umkristallisiert, bei 145 bis 146"C schmilzt.Example 2 2- {N- [3-phenyl-3-thienyl- (2) -3-hydroxy-propyl- (1)] -amino) 3 - (p-chlorophenyl) -propane The Grignard compound is prepared in the usual way from 3.5 g (0.145 mol) of Mg turnings and 23.6 g (0.145 mol) of 2-bromothiophene in 50 ml of absolute ether. This solution is mixed with a suspension of 23 g (0.068 mol) of (N- [3-p-chlorophenyl-propyl- (2) -aminoj-ethyl} -phenyl-ketone -HCl in 250 ml of absolute ether and the mixture is boiled for 4 hours. Then it is decomposed with 20 g of ammonium chloride in 100 ml of water, the ether solution is dried with potash and distilled. This gives 12.8 g of base with a boiling point of 250 to 252 ° C. In isopropanolic solution with isopropanolic maleic acid solution a maleate is obtained which , recrystallized from isopropanol, melts at 145 to 146 "C.

Beispiel 3 2N- [3-Phenyl-3-thienyl-(2)-3-hydroxy-propyl-(1)]-aminoT-3-(4-methoxv-Dhenvl)-DroDan Aus 6,2 g (0,252 Mol) Mg-Spänen und 41 g (0,252 Mol) 2-Bromthiophen wird in 100 ml abso- gutem Sicher in üblicher Weise die Grignardverbindung bereitet. Dazu läßt man bei 0°C 42 g (0,126 Mol) 2-{N-[3-Phenyl-3-oxo-propyl-(1)]-amino}-3-(4-methoxy-phenyl)-propan-HCl, in 300 ml ababsolutem Äther suspendiert, tropfen. Nach einer halben Stunde wird mit 50 g Ammoniumchlorid in 150 ml Wasser unter Kühlung zersetzt. Die ätherische Lösung wird über Pottasche getrocknet und das HCl-Salz der Base unter Kühlen mit einer Lösung on HCI in Isopropanol gefällt. Nach dem Umkristallisieren aus Essigester-Äthanol (2: 1) erhält man 28 g HCl-Salz vom F. 160 bis 161"C.Example 3 2N- [3-Phenyl-3-thienyl- (2) -3-hydroxy-propyl- (1)] -aminoT-3- (4-methoxv-Dhenvl) -DroDane The Grignard compound is prepared in 100 ml of absolute safety in the usual way from 6.2 g (0.252 mol) of Mg turnings and 41 g (0.252 mol) of 2-bromothiophene. For this purpose, 42 g (0.126 mol) of 2- {N- [3-phenyl-3-oxo-propyl- (1)] -amino} -3- (4-methoxyphenyl) -propane-HCl are allowed at 0 ° C , suspended in 300 ml of absolute ether, drip. After half an hour, 50 g of ammonium chloride in 150 ml of water are used to decompose with cooling. The ethereal solution is dried over potash and the HCl salt of the base is precipitated with a solution of HCl in isopropanol while cooling. After recrystallization from ethyl acetate-ethanol (2: 1), 28 g of HCl salt with a melting point of 160 to 161 ° C. are obtained.

Beispiel 4 2N- [3-Phenyl-3-thienyl-(2)-3-hydroxy-propyl-(1)]-amino}-3-phenyl-propan Aus 2,3 g (0,4 Mol) Lithium und 48 g (0,4 Mol) Brombenzol wird in 200 ml absolutem Äther in üblicher Weise die Phenyllithiumlösung bereitet.Example 4 2N- [3-Phenyl-3-thienyl- (2) -3-hydroxypropyl- (1)] -amino} -3-phenyl-propane The phenyllithium solution is prepared in the usual way from 2.3 g (0.4 mol) of lithium and 48 g (0.4 mol) of bromobenzene in 200 ml of absolute ether.

Diese Lösung wird bei Zimmertemperatur mit einer Suspension von 31 g (0,1 Mol) (2- [3-Phenyl-propyl-(2)-amino]-äthyl}-thienyl-(2)-keton-HCl in 200 ml absolutem Äther versetzt. Nach einer Stunde wird mit 50 g Ammoniumchlorid in 150 ml Wasser zersetzt, die Ätherlösung mit Pottasche getrocknet und das Lösungsmittel abdestilliert. Man erhält 13 g Base vom Kp.1 = 225 bis 235"C. In ätherischer Lösung wird mit isopropanolischer MCl ein Hydrochlorid erhalten, das, aus Isopropanol umkristallisiert, bei 190"C schmilzt.This solution is at room temperature with a suspension of 31 g (0.1 mol) (2- [3-phenyl-propyl- (2) -amino] -ethyl} -thienyl- (2) -ketone-HCl in 200 ml of absolute ether added. After one hour, 50 g of ammonium chloride in 150 ml of water decomposed, the ethereal solution dried with potash and the solvent distilled off. 13 g of base with a boiling point of 225 to 235 ° C. are obtained. In an ethereal solution a hydrochloride is obtained with isopropanolic MCl, which, recrystallized from isopropanol, melts at 190 "C.

Claims (1)

Patentanspruch: Weitere Ausbildung des Verfahrens zur Herstellung von basischen Thiophenderivaten der allgemeinen Formel in der R1 ein Wasserstoffatom oder eine niedrigmolekulare Alkylgruppe und R2 ein Wasserstoff- oder Halogenatom oder eine Hydroxyl- oder eine Alkoxygruppe bedeutet, und deren Salze nach Patent 1 194 424, dadurch gekennzeichnet, daß man in an sich bekannter Weise a) eine Verbindung der allgemeinen Formel an Stelle von 2-Thienyllithium mit 2-Thienylmagnesiumbromid umsetzt oder b) eine Verbindung der allgemeinen Formel an Stelle von Phenylmagnesiumbromid mit Phenyllithium umsetzt und gegebenenfalls die erhaltenen Basen in ihre Salze überführt.Claim: Further development of the process for the preparation of basic thiophene derivatives of the general formula in which R1 is a hydrogen atom or a low molecular weight alkyl group and R2 is a hydrogen or halogen atom or a hydroxyl or an alkoxy group, and the salts thereof according to Patent 1,194,424, characterized in that a) a compound of the general formula in place of 2-thienyllithium with 2-thienylmagnesium bromide or b) a compound of the general formula instead of phenylmagnesium bromide is reacted with phenyllithium and, if necessary, the bases obtained are converted into their salts.
DED40465A 1961-11-10 1962-12-07 Process for the preparation of new pharmaceutically valuable thiophene compounds Pending DE1213851B (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DED37431A DE1194424B (en) 1961-11-10 1961-11-10 Process for the preparation of basic thiophene derivatives
CH1147162A CH429760A (en) 1961-11-10 1962-09-28 Process for the preparation of new pharmaceutically valuable compounds
FI621835A FI42572C (en) 1961-11-10 1962-10-11 Process for the preparation of therapeutically valuable basic thiophene derivatives
BR143797/62A BR6243797D0 (en) 1961-11-10 1962-10-15 PROCESS TO PRODUCE NEW VALUABLE PHARMACEUTICAL COMPOUNDS
GB39127/62A GB970445A (en) 1961-11-10 1962-10-16 Thiophene derivatives
SE11930/62A SE311168B (en) 1961-11-10 1962-11-07
DK483762AA DK105813C (en) 1961-11-10 1962-11-09 Process for the preparation of basic thiophene derivatives or salts or quaternary ammonium compounds thereof.
DK246264AA DK105595C (en) 1961-11-10 1962-11-09 Process for the preparation of basic thiophene derivatives or salts or quaternary ammonium compounds thereof.
DED40465A DE1213851B (en) 1961-11-10 1962-12-07 Process for the preparation of new pharmaceutically valuable thiophene compounds
BE628104A BE628104A (en) 1961-11-10 1963-02-06 Process for the preparation of novel phenyl-thienyl-alkanos derivatives
SE13233/63A SE309601B (en) 1961-11-10 1963-11-29
FI691216A FI42577C (en) 1961-11-10 1969-04-24 Method for the preparation of basic thiophene derivatives affecting the cardiac circulation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DED37431A DE1194424B (en) 1961-11-10 1961-11-10 Process for the preparation of basic thiophene derivatives
DED40401A DE1199783B (en) 1962-11-30 1962-11-30 Process for the preparation of basic thiophene derivatives
DED40465A DE1213851B (en) 1961-11-10 1962-12-07 Process for the preparation of new pharmaceutically valuable thiophene compounds
DED40471A DE1219038B (en) 1962-12-08 1962-12-08 Process for the preparation of thiophene compounds

Publications (1)

Publication Number Publication Date
DE1213851B true DE1213851B (en) 1966-04-07

Family

ID=45560586

Family Applications (2)

Application Number Title Priority Date Filing Date
DED37431A Pending DE1194424B (en) 1961-11-10 1961-11-10 Process for the preparation of basic thiophene derivatives
DED40465A Pending DE1213851B (en) 1961-11-10 1962-12-07 Process for the preparation of new pharmaceutically valuable thiophene compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DED37431A Pending DE1194424B (en) 1961-11-10 1961-11-10 Process for the preparation of basic thiophene derivatives

Country Status (8)

Country Link
BE (1) BE628104A (en)
BR (1) BR6243797D0 (en)
CH (1) CH429760A (en)
DE (2) DE1194424B (en)
DK (2) DK105813C (en)
FI (2) FI42572C (en)
GB (1) GB970445A (en)
SE (2) SE311168B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1921453C3 (en) * 1969-04-26 1973-04-19 Degussa Basic dithienyl derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB646198A (en) * 1946-02-28 1950-11-15 Winthrop Stearns Inc Improvements in or relating to the preparation of antispasmodic agents
GB657301A (en) * 1948-02-25 1951-09-19 Wellcome Found Improvements in and relating to the preparation of substituted amino-alcohols and derivatives thereof
GB702269A (en) * 1950-01-06 1954-01-13 Wellcome Found Tertiary allylamines of therapeutic value and the production thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1921453C3 (en) * 1969-04-26 1973-04-19 Degussa Basic dithienyl derivatives

Also Published As

Publication number Publication date
FI42577C (en) 1970-09-14
DK105813C (en) 1966-11-14
FI42572B (en) 1970-06-01
FI42572C (en) 1970-09-14
CH429760A (en) 1967-02-15
BR6243797D0 (en) 1973-05-24
DE1194424B (en) 1965-06-10
SE309601B (en) 1969-03-31
DK105595C (en) 1966-10-17
BE628104A (en) 1963-05-29
GB970445A (en) 1964-09-23
SE311168B (en) 1969-06-02
FI42577B (en) 1970-06-01

Similar Documents

Publication Publication Date Title
DE2556110C3 (en) 2- (3-Alkylamino-2-hydroxypropoxy) -3cyanpyridines, their preparation and pharmaceutical use
DE2047658A1 (en)
US3254094A (en) 3-imino-2, 1-benzisothiazoles
DE1213851B (en) Process for the preparation of new pharmaceutically valuable thiophene compounds
DE2259222A1 (en) NEW, 1,1-DIOXOTHIAZOLIDIN-4-ONE AND THE METHOD FOR THE PREPARATION
US3536723A (en) P - (2 - alkyloxy - benzoyl) - aminobenzoates of n - dialkylamine - alkyl and their quaternary salts
DE3538063A1 (en) 6-PHENETHYLAMINOALKYL-FURO- (3,4-C) -PYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THESE THERAPEUTIC COMPOSITIONS
DE1793580A1 (en) Basic terpene ether derivatives
DE1445648C (en) Homopiperazindenvate
DE1219038B (en) Process for the preparation of thiophene compounds
DE2518516C3 (en) 2- (3,45-trimethoxybenzyl) -3,4-dimethylpyridine
DE1948924C3 (en) 13-Diallyl-4-chloro-5-ethyl-uracil and process for its preparation
DE1695695C3 (en) Process for the preparation of 2-aminofuro square bracket to 2,3-square bracket to thiazoles
AT156164B (en) Process for the preparation of haloalkyl or haloaralkylamines.
DE2747121A1 (en) 6- (M-AMINOPHENYL-2,3,5,6-TETRAHYDROIMIDAZO SQUARE CLAMP ON 2.1-B SQUARE CLAMP FOR THIAZOLE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
DE964500C (en) Production of ª ‡ -disubstituted arylacetonitriles with analgesic effects
DE1543732C (en) Process for the preparation of 1,1 diphenyl 1 alkoxy-3 aminopropanes
DE2116548C3 (en) Process for the production of 2,6-dicyanotrichloropyridine
DE961538C (en) Process for the production of new derivatives of 1-alkyl-4-phenyl-piperidyl- (4) -alkyl-ketones
AT203496B (en) Process for the preparation of new tertiary amines
DE1117600B (en) Process for the preparation of quaternary ammonium salts effective against nematodes
CH390940A (en) Process for the preparation of 1,4-benzdioxane derivatives
AT356665B (en) METHOD FOR PRODUCING NEW CHINUCLIDINE DERIVATIVES, THEIR STEREOISOMERS, OPTICAL ISOMERS AND SALTS
DE1044098B (en) Process for the production of spasmolytic dialkylamine derivatives
DE959015C (en) Process for the preparation of new pharmacologically active basic esters and their salts